Literature DB >> 15243817

Seroepidemiology of rubella in northern Greece.

G Gioula1, E Diza-Mataftsi, S Alexiou-Daniel, V Kyriazopoulou-Dalaina.   

Abstract

In light of two rubella outbreaks in northern Greece during the last decade (1993 and 1999) and periodic changes to the immunization strategy, the present study was conducted to determine the current status of rubella immunity in this region. Among the 729 subjects studied the total vaccination rate was 30.4% and the seroprevalence rate was 82.4% (odds ratio, 0.618; 95% confidence interval, 0.415-0.921). A higher seroprevalence (83.2%) was observed among people born before 1989, when the national rubella immunization program was introduced, compared to the individuals born after 1989 (67.1%; P=0.000). Among women of reproductive age (i.e. 16-40 years), who represented 69.6% of the study population, 10.3% were susceptible to rubella and only 16.4% were vaccinated. The results indicate a comprehensive policy is still needed in order to eliminate rubella and congenital rubella syndrome in Greece.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15243817     DOI: 10.1007/s10096-004-1172-y

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  5 in total

1.  The European Sero-Epidemiology Network: standardizing the enzyme immunoassay results for measles, mumps and rubella.

Authors:  N Andrews; R G Pebody; G Berbers; C Blondeau; P Crovari; I Davidkin; P Farrington; F Fievet-Groyne; G Gabutti; E Gerike; C Giordano; L Hesketh; T Marzec; P Morgan-Capner; K Osborne; A M Pleisner; M Raux; A Tischer; U Ruden; M Valle; E Miller
Journal:  Epidemiol Infect       Date:  2000-08       Impact factor: 2.451

Review 2.  Increase in congenital rubella occurrence after immunisation in Greece: retrospective survey and systematic review.

Authors:  T Panagiotopoulos; I Antoniadou; E Valassi-Adam
Journal:  BMJ       Date:  1999-12-04

3.  The history and medical consequences of rubella.

Authors:  L Z Cooper
Journal:  Rev Infect Dis       Date:  1985 Mar-Apr

4.  Consequences of confirmed maternal rubella at successive stages of pregnancy.

Authors:  E Miller; J E Cradock-Watson; T M Pollock
Journal:  Lancet       Date:  1982-10-09       Impact factor: 79.321

5.  Effect of selective vaccination on rubella susceptibility and infection in pregnancy.

Authors:  C L Miller; E Miller; P J Sequeira; J E Cradock-Watson; M Longson; E C Wiseberg
Journal:  Br Med J (Clin Res Ed)       Date:  1985-11-16
  5 in total
  3 in total

1.  Seroprevalence of measles, rubella, and mumps antibodies in Catalonia, Spain: results of a cross-sectional study.

Authors:  A Domínguez; P Plans; J Costa; N Torner; N Cardenosa; J Batalla; A Plasencia; L Salleras
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2006-05       Impact factor: 3.267

2.  Rubella seroprofile of the Italian population: an 8-year comparison.

Authors:  M C Rota; A Bella; G Gabutti; C Giambi; A Filia; M Guido; A De Donno; P Crovari; M L Ciofi Degli Atti
Journal:  Epidemiol Infect       Date:  2006-11-01       Impact factor: 2.451

3.  Seroepidemiological study of rubella in Vojvodina, Serbia: 24 years after the introduction of the MMR vaccine in the national immunization programme.

Authors:  Aleksandra Patić; Mirjana Štrbac; Vladimir Petrović; Vesna Milošević; Mioljub Ristić; Ivana Hrnjaković Cvjetković; Snežana Medić
Journal:  PLoS One       Date:  2020-01-13       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.